Show
Sort by
-
- Journal Article
- A1
- open access
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic : an ESTRO-ASTRO consensus statement q
-
Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation
-
Estimating the number of fractions by tumour site for European countries in 2012 and 2025 : an ESTRO-HERO analysis
-
Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?
-
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
-
Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines
-
Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer
-
CHART in lung cancer: economic evaluation and incentives for implementation
-
Dose-intensified accelerated vindesine-ifosfamide-cisplatin (VIP) chemotherapy followed by high-dose accelerated hyperfractionated radiotherapy in patients with pathologically proven stage IIIB non-small cell lung cancer: a feasibility study